Lumos Pharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $726 | $488 | $165 | $826 |
Gross Profit | 726 | 486 | 163 | 808 |
EBITDA | -7,640 | -7,821 | -10,860 | -9,986 |
EBIT | -7,823 | -10,862 | -10,029 | |
Net Income | -7,467 | -7,551 | -10,441 | -9,457 |
Net Change In Cash | 726 | 488 | 165 | 826 |
Free Cash Flow | -5,006 | -6,380 | -12,894 | -20,598 |
Cash | 13,519 | 16,799 | 23,179 | 35,078 |
Basic Shares | 8,327 | 8,112 | 8,104 | 8,101 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,051 | $1,523 | $230 | $168 |
Gross Profit | 2,051 | 1,523 | 230 | 168 |
EBITDA | -36,570 | -31,991 | -31,144 | -25,719 |
EBIT | -36,614 | -32,040 | -31,347 | -26,303 |
Net Income | -34,034 | -31,062 | -30,430 | -5,663 |
Net Change In Cash | 2,051 | 1,523 | 230 | 168 |
Cost of Revenue | 93,727 | |||
Free Cash Flow | -31,095 | -26,644 | -29,678 | -23,027 |
Cash | 35,078 | 56,007 | 94,809 | 98,679 |
Basic Shares | 8,145 | 8,373 | 8,334 | 6,777 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.90 |
2024-06-30 | -$0.93 |
2024-03-31 | -$1.29 |
2023-12-31 | -$1.17 |
